Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share (Tables)

v3.24.1.1.u2
Net Loss Per Share (Tables)
3 Months Ended
Mar. 31, 2024
Earnings Per Share [Abstract]  
Schedule of Anti-Dilutive Securities that Could Potentially be Dilutive in Future

The table below represents the anti-dilutive securities that could potentially be dilutive in the future for the periods presented:

 

 

As of March 31,

 

(in shares of common stock)

 

2024

 

 

2023

 

Stock options

 

 

949,151

 

 

 

1,148,129

 

Restricted stock units

 

 

21,493,923

 

 

 

17,617,600

 

FP Combination Warrants

 

 

8,291,704

 

 

 

8,291,704

 

Combination Warrants

 

 

2,763,902

 

 

 

2,763,902

 

Public Warrants

 

 

19,221,960

 

 

 

19,221,960

 

Private Placement Warrants

 

 

78,000

 

 

 

78,000

 

2027 Warrants

 

 

17,253,279

 

 

 

17,253,279

 

RDO Warrants

 

 

29,000,000

 

 

 

 

Placement Agent Warrants

 

 

2,030,000

 

 

 

 

CMPO Warrants

 

 

23,214,290

 

 

 

 

CMPO Placement Agent Warrants

 

 

1,625,000

 

 

 

 

PIPE Investment Obligation

 

 

8,587,786

 

 

 

12,228,261

 

Conversion Option Derivative

 

 

39,696,788

 

 

 

35,956,013

 

Schedule of Computations of Basic and Diluted Net Loss Per Share

The computations of basic and diluted net loss per share for the periods presented were as follows:

 

 

 

Three Months Ended March 31,

 

(in thousands, except per share and share amounts)

 

2024

 

 

2023

 

Numerator:

 

 

 

 

 

 

Net loss

 

$

(53,244

)

 

$

(54,445

)

Denominator:

 

 

 

 

 

 

Weighted-average shares outstanding - basic and diluted

 

 

201,442,209

 

 

 

144,062,103

 

Net loss per share - basic and diluted

 

$

(0.26

)

 

$

(0.38

)